- 英文名称
- (S)-(-)-3-TERT-BUTOXYCARBONYL-4-METHOXYCARBONYL-2,2-DIMETHYL-1,3-OXAZOLIDINE
- 分子式
- C12H21NO5
- 分子量
- 259.3
- 中文别名
- (S)-(-)-3-叔丁氧羰基-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷; (S)-(-)-3-BOC-4-甲氧羰基-2,2-二甲基-1,3-噁唑烷; (S)-(-)-3-(叔丁氧羰基)-2,2-二甲基-4-唑啉羧酸甲酯; (S)-(-)-3-BOC-2,2-二甲基-4-唑啉羧酸甲酯; (S)-(-)-3-BOC-2,2-二甲基-4-噁唑啉羧酸甲酯; (S)-(-)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷; (S)-(-)-3-叔丁氧羰基-2,2-二甲基-4-恶唑烷羧酸甲酯; (S)-(-)-3-(叔丁氧羰基)-2,2-二甲基-4-噁唑啉羧酸甲酯; 3-tert-Butyl 4-methyl (4S)-2,2-dimethyl-1,3-oxazolidine-3,4-dicarboxylate; (S)-N-BOC-2,2-DIMETHYLOXAZOLINDINE-4-CARBOXYLIC ACID METHYL ESTER; 2,2-DIMETHYL OXAZOLIDINE-3,4-DICARBOXYLIC ACID 3-TERT-BUTYL ESTER 4-METHYL ESTER; 3-(1,1-DIMETHYLETHYL)-4-METHYL-(S)-2,2-DIMETHYL-3,4-OXAZOLIDINE CARBOXYLATE; 3-(1,1-DIMETHYLETHYL)-4-METHYL-(S)-2,2-DIMETHYL-3,4-OXAZOLIDINEDICARBOXYLATE; 3,4-Oxazolidinedicarboxylic acid, 2,2-diMethyl-, 3-(1,1-diMethylethyl) 4-Methyl ester, (4S)-; 3-O-tert-butyl 4-O-methyl (4S)-2,2-dimethyl-1,3-oxazolidine-3,4-dicarboxylate; Methyl (S)-(-)-3-tert-Butoxycarbonyl-2,2-dimethyl-4-oxazolidinecarboxylate; 4-methyl (S)-2,2-dimethyl-3,4-oxazolidinedicarboxylate; N-tert-butoxycarbonyl 4(S)-(1'-methoxycarbonyl)-2,2-dimethyl-1,3-oxazolidine; Methyl (S)-(-)-3-Boc-2,2-dimethyl-4-oxazolidinecarboxylate; (S)-3-Boc-2,2-Dimethyl-oxazolidine-4-carboxylic acid methyl ester; Methyl(4S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidine-4-carboxylate; (S)-2,2-dimethyl-oxazolidine-3,4-dicarboxylic acid 3-tert-butyl ester 4-methyl ester; 2,2-dimethyloxazolidine-3,4-dicarboxylic acid 3-tert-butyl ester 4-methyl ester; (S)-(-)-3-Boc-4-methoxycarbonyl-2,2-dimethyl-1,3-oxazolidine; 4-Methyl 3-(2-methyl-2-propanyl) (4S)-2,2-dimethyl-1,3-oxazolidine-3,4-dicarboxylate; Methyl (S)-(-)-3-(tert-butoxycarbonyl)-2,2-dimethyl-4-oxazolidinecarboxylate; Garner's ester; Methyl (4S)-3-tert-butoxycarbonyl-2,2-dimethyl-1,3-oxazolidine-4-carboxylate
- 用途
- 作为有用的中间体,用于改进加纳尔醛及其类似物的合成;含恶唑环的有机化合物作为药物已广泛应用于临床,在克服临床耐药性、治疗感染性疾病等方面起不可替代的作用。